BioSpace News Archive

Fujirebio Diagnostics Lumipulse® G β-Amyloid Ratio (1-42/1-40) In Vitro Diagnostic Test Receives Marketing Authorization for the Assessment of Alzheimer’s Disease.

Ashvattha Therapeutics announced that Jeffrey Cleland, Ph.D., Chairman, CEO & President of Ashvattha, will provide a corporate overview followed by a moderated Q&A at the UBS Global Healthcare Conference 2022 taking place in New York, NY, May 23-25, 2022.

CODA Biotherapeutics, Inc. today announced that preclinical data from the Company’s focal epilepsy program will be featured as a poster presentation at the American Society of Gene & Cell Therapy 25th Annual Meeting being held virtually and in person, May 16-19, 2022, in Washington, D.C.

Stryker announced that on May 4, 2022, the company’s board of directors approved board leadership and committee assignment changes, naming Sherilyn S. McCoy to replace Allan C. Golston as Lead Independent Director, and Mary K. Brainerd to replace Ms. McCoy as Chair of the Governance and Nominating Committee.

Eyenovia, Inc. announced that the Company will release financial results for the first quarter ended March 31, 2022 on Thursday, May 12, 2022, after the markets close.

Neoleukin Therapeutics, Inc. announced that Jonathan Drachman, M.D., Chief Executive Officer, will participate in two upcoming investor conferences.

Lineage Cell Therapeutics, Inc. today announced that it will report its first quarter 2022 financial and operating results on Thursday, May 12, 2022, following the close of the U.S. financial markets.

Artiva Biotherapeutics, Inc. today announced the appointment of Edith A. Perez, M.D., as a member of the Company’s Board of Directors.

Mycovia Pharmaceuticals, Inc. will sponsor a product theater showcase for its recently FDA-approved VIVJOA™ (oteseconazole capsules), during the 2022 American College of Obstetricians and Gynecologists (ACOG) Annual Meeting.

Sun Nuclear Corporation, a wholly-owned subsidiary of Mirion Technologies, Inc., will feature its comprehensive solutions portfolio for independent, integrated Quality Management of Radiation Therapy and Diagnostic Imaging at the ESTRO 2022 Congress, held May 6-10 in Copenhagen, Denmark.